Phase I Study to Determine the Absorption, Distribution, Metabolism and Excretion of Esreboxetine
Clinical trial NCT00800956 · COMPLETED
Trial details
- NCT number
- NCT00800956
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-02-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.